BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: McEvoy CR, Fox SB, Prall OWJ. Emerging entities in NUTM1-rearranged neoplasms. Genes Chromosomes Cancer 2020;59:375-85. [PMID: 32060986 DOI: 10.1002/gcc.22838] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 10.7] [Reference Citation Analysis]
Number Citing Articles
1 Barletta JA, Gilday SD, Afkhami M, Bell D, Bocklage T, Boisselier P, Chau NG, Cipriani NA, Costes-Martineau V, Ghossein RA, Hertzler HJ, Kramer AM, Limaye S, Lopez CA, Ng TL, Weissferdt A, Xu B, Zhang S, French CA. NUTM1 -rearranged Carcinoma of the Thyroid : A Distinct Subset of NUT Carcinoma Characterized by Frequent NSD3 - NUTM1 Fusions. Am J Surg Pathol 2022;46:1706-15. [PMID: 36040068 DOI: 10.1097/PAS.0000000000001967] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Wu B, Shen L, Peng G, Li Y, Zhou Z, Li J, Huang X, Zhou Q, Jiang H, Huang J, Ding Q, Zhang Z, Qin Y, Hong X, Shi L, Zou Z, Yao J, Zhang J, Liu D, Wan C, Wu G, Song L, Chen S, Yi J, Yang K. Molecular characteristics of pediatric nasopharyngeal carcinoma using whole-exome sequencing. Oral Oncology 2022;135:106218. [DOI: 10.1016/j.oraloncology.2022.106218] [Reference Citation Analysis]
3 Lemelle L, Flaadt T, Fresneau B, Moya-Plana A, Timmermann B, Roganovic J, Ferrari A, Fichera G, Lauer UM, Ben-Ami T, Schneider DT, Vokuhl C, Bolle S, Fox E, DuBois SG, Rodriguez-Galindo C, Bisogno G, Surun A, Brecht IB, Orbach D. NUT Carcinoma in Children and Adolescents: The Expert European Standard Clinical Practice Harmonized Recommendations. J Pediatr Hematol Oncol 2022. [PMID: 36219702 DOI: 10.1097/MPH.0000000000002568] [Reference Citation Analysis]
4 Lauer UM, Hinterleitner M, Horger M, Ohnesorge PV, Zender L. NUT Carcinoma—An Underdiagnosed Malignancy. Front Oncol 2022;12:914031. [DOI: 10.3389/fonc.2022.914031] [Reference Citation Analysis]
5 Nakagawa K, Okabayashi A, Tohda R. A Case of Eccrine Poromatosis Followed by Chronic Myelo-monocytic Leukemia in the Two Years Later. Nishinihon J Dermatol 2022;84:211-214. [DOI: 10.2336/nishinihonhifu.84.211] [Reference Citation Analysis]
6 Marchocki Z, Tone A, Virtanen C, de Borja R, Clarke B, Brown T, May T. Impact of neoadjuvant chemotherapy on somatic mutation status in high-grade serous ovarian carcinoma. J Ovarian Res 2022;15. [DOI: 10.1186/s13048-022-00983-5] [Reference Citation Analysis]
7 Rousseaux S, Reynoird N, Khochbin S. NUT Is a Driver of p300-Mediated Histone Hyperacetylation: From Spermatogenesis to Cancer. Cancers 2022;14:2234. [DOI: 10.3390/cancers14092234] [Reference Citation Analysis]
8 Georgantzoglou N, Aghighi M, Cote G, Hung YP, Kerr DA, Pettus J, Linos K. Primary Spindle Cell Sarcoma of the Lung with MGA::NUTM1 Fusion: An Extremely Rare Case of a Potentially Emerging Entity and Review of the Literature. Int J Surg Pathol 2022;:10668969221092125. [PMID: 35388715 DOI: 10.1177/10668969221092125] [Reference Citation Analysis]
9 Lemelle L, Moya-plana A, Dumont B, Fresneau B, Laprie A, Claude L, Deneuve S, Cordero C, Pierron G, Couloigner V, Bernard S, Cardoen L, Brisse HJ, Jehanno N, Metayer L, Fréneaux P, Helfre S, Kolb F, Thariat J, Réguerre Y, Orbach D. NUT carcinoma in children, adolescents and young adults. Bulletin du Cancer 2022. [DOI: 10.1016/j.bulcan.2022.01.015] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Chen M, Zhao S, Liang Z, Wang W, Zhou P, Jiang L. NUT carcinoma of the parotid gland: report of two cases, one with a rare ZNF532-NUTM1 fusion. Virchows Arch. [DOI: 10.1007/s00428-021-03253-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Allison DB, Rueckert J, Cornea V, Lee CY, Dueber J, Bocklage T. Thyroid Carcinoma with NSD3::NUTM1 Fusion: a Case with Thyrocyte Differentiation and Colloid Production. Endocr Pathol 2022. [PMID: 34997561 DOI: 10.1007/s12022-021-09700-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
12 Jiang H, Wang C, Hou Z, Wang Y, Qiao J, Li H. Case report: NUT carcinoma with MXI1::NUTM1 fusion characterized by abdominopelvic lesions and ovarian masses in a middle-aged female. Front Oncol 2022;12:1091877. [PMID: 36741693 DOI: 10.3389/fonc.2022.1091877] [Reference Citation Analysis]
13 Luo W, Stevens TM, Stafford P, Miettinen M, Gatalica Z, Vranic S. NUTM1-Rearranged Neoplasms-A Heterogeneous Group of Primitive Tumors with Expanding Spectrum of Histology and Molecular Alterations-An Updated Review. Curr Oncol 2021;28:4485-503. [PMID: 34898574 DOI: 10.3390/curroncol28060381] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
14 Gasljevic G, Matter MS, Blatnik O, Unk M, Dirnhofer S. NUT Carcinoma: A Clinical, Morphological and Immunohistochemical Mimicker-The Role of RNA Sequencing in the Diagnostic Procedure. Int J Surg Pathol 2021;:10668969211047981. [PMID: 34738485 DOI: 10.1177/10668969211047981] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Nishimura Y, Ryo E, Yamazaki N, Yatabe Y, Mori T. Cutaneous Primary NUT Carcinoma With BRD3-NUTM1 Fusion. Am J Surg Pathol 2021;45:1582-4. [PMID: 34482332 DOI: 10.1097/PAS.0000000000001801] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
16 Li X, Shi H, Zhang W, Bai C, He M, Ta N, Huang H, Ning Y, Fang C, Qin H, Dong Y. Immunotherapy and Targeting the Tumor Microenvironment: Current Place and New Insights in Primary Pulmonary NUT Carcinoma. Front Oncol 2021;11:690115. [PMID: 34660264 DOI: 10.3389/fonc.2021.690115] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
17 Patel SA, Singer B, Shen C, Zanation AM, Yarbrough WG, Weiss J. A case of metastatic NUT carcinoma with prolonged response on gemcitabine and nab-paclitaxel. Clin Case Rep 2021;9:e04616. [PMID: 34429997 DOI: 10.1002/ccr3.4616] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Iacobucci I, Kimura S, Mullighan CG. Biologic and Therapeutic Implications of Genomic Alterations in Acute Lymphoblastic Leukemia. J Clin Med 2021;10:3792. [PMID: 34501239 DOI: 10.3390/jcm10173792] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
19 Rubio Gonzalez B, Ortiz MV, Ross DS, Busam KJ. Skin adnexal carcinoma with BRD3-NUTM2B fusion. J Cutan Pathol 2021. [PMID: 34296453 DOI: 10.1111/cup.14107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Xu B, Ghossein R, Ho A, Viswanathan K, Khimraj A, Saliba M, Cracchiolo JR, Katabi N. Diagnostic discrepancy in second opinion reviews of primary epithelial neoplasms involving salivary gland: An 11-year experience from a tertiary referral center focusing on useful pathologic approaches and potential clinical impacts. Head Neck 2021;43:2497-509. [PMID: 33893750 DOI: 10.1002/hed.26719] [Reference Citation Analysis]
21 Yuan L, Chen X, Cao X, Wang F, Zhang Y, Ma X, Cao P, Fang J, Chen J, Zhou X, Wu Q, Nie D, Liu M, Liu H. Identification of a novel AVEN-NUTM1 fusion gene in acute myeloid leukemia. Int J Lab Hematol 2021;43:O207-10. [PMID: 33755317 DOI: 10.1111/ijlh.13519] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Hung YP, Chen AL, Taylor MS, Huynh TG, Kem M, Selig MK, Nielsen GP, Lennerz JK, Azzoli CG, Dagogo-Jack I, Kradin RL, Mino-Kenudson M. Thoracic nuclear protein in testis (NUT) carcinoma: expanded pathological spectrum with expression of thyroid transcription factor-1 and neuroendocrine markers. Histopathology 2021;78:896-904. [PMID: 33231320 DOI: 10.1111/his.14306] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
23 Macagno N, Kervarrec T, Sohier P, Poirot B, Haffner A, Carlotti A, Balme B, Castillo C, Jullie ML, Osio A, Lehmann-Che J, Frouin E, Battistella M. NUT Is a Specific Immunohistochemical Marker for the Diagnosis of YAP1-NUTM1-rearranged Cutaneous Poroid Neoplasms. Am J Surg Pathol 2021;45:1221-7. [PMID: 33739783 DOI: 10.1097/PAS.0000000000001693] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
24 Prall OWJ, Thio N, Yerneni S, Kumar B, McEvoy CR. A NUT carcinoma lacking squamous differentiation and expressing TTF1. Pathology 2021;53:663-6. [PMID: 33454140 DOI: 10.1016/j.pathol.2020.09.027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
25 Sopfe J, Greffe B, Treece AL. Metastatic NUT Midline Carcinoma Treated With Aggressive Neoadjuvant Chemotherapy, Radiation, and Resection: A Case Report and Review of the Literature. J Pediatr Hematol Oncol 2021;43:e73-5. [PMID: 32555032 DOI: 10.1097/MPH.0000000000001860] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
26 McEvoy CR, Holliday H, Thio N, Mitchell C, Choong DY, Yellapu B, Leong HS, Xu H, Lade S, Browning J, Takano EA, Byrne DJ, Gill AJ, Duong CP, Li J, Fellowes AP, Fox SB, Swarbrick A, Prall OWJ. A MXI1-NUTM1 fusion protein with MYC-like activity suggests a novel oncogenic mechanism in a subset of NUTM1-rearranged tumors. Lab Invest 2021;101:26-37. [PMID: 32873880 DOI: 10.1038/s41374-020-00484-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
27 Zhu N, Hou J. Assessing immune infiltration and the tumor microenvironment for the diagnosis and prognosis of sarcoma. Cancer Cell Int 2020;20:577. [PMID: 33292275 DOI: 10.1186/s12935-020-01672-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
28 Parra O, Kerr DA, Bridge JA, Loehrer AP, Linos K. A case of YAP1 and NUTM1 rearranged porocarcinoma with corresponding immunohistochemical expression: Review of recent advances in poroma and porocarcinoma pathogenesis with potential diagnostic utility. J Cutan Pathol 2021;48:95-101. [PMID: 32757412 DOI: 10.1111/cup.13832] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]